More than one
million people in Africa have checked their medicines using the
text-message based verification service developed by Sproxil, says
the firm, marking a major milestone for the company.
Sproxil's Mobile Product Authentication (MPA) technology has been applied to medicines sold in Nigeria by GlaxoSmithKline, Johnson & Johnson and Merck KGaA, amongst others, with additional clients recently signed in India.
"Knowing that consumers have used our technology more than one million times to validate their medication demonstrates both the simplicity of our solution, as well as the immense demand for it," commented Dr. Ashifi Gogo, chief executive of Sproxil.
"Consumers no longer judge the authenticity of their product by its appearance; they verify it," he added.
Gogo added that support from regulatory authorities such as the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria and the Pharmacy and Poisons Board (PPB) in Kenya has helped the company grow significantly over a short period.